Pharmacological properties of 5-hydroxytryptamine4 receptor antagonists on constitutively active wild-type and mutated receptors

被引:50
作者
Claeysen, S
Sebben, M
Bécamel, C
Eglen, RM
Clark, RD
Bockaert, J
Dumuis, A
机构
[1] Inst Natl Sante & Rech Med Pharmacol Endocrinol, CNRS, UPR 9023, F-34094 Montpellier 5, France
[2] Roche Biosci, Neurobiol Unit, Biol Res Ctr, Palo Alto, CA USA
关键词
D O I
10.1124/mol.58.1.136
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We studied the pharmacological properties of twenty-four 5-hydroxytryptamine (5-HT)(4) receptor ligands known to act as antagonists on 5-HT4 receptors positively coupled to adenylyl cyclase endogenously expressed in mouse colliculi neurons. In COS-7 cells expressing human or mouse 5-HT4(a) receptors (100-8000 fmol/mg of protein), we found neutral antagonists, partial agonists, and inverse agonists. The majority of neutral antagonists belong to the benzodioxanyl ketone class, whereas partial agonists belong to different chemical classes. We found only two inverse agonists, GR 125487 and SB 207266, which are both indoles. Analysis of pharmacological characteristics of the constitutively active wild-type and constitutively active mutated receptors revealed that 1) the ratio between the efficiencies of the full agonist 5-HT and the partial agonist RS 23597 was invariable when the receptor density increased, but was dependent on receptor structure; 2) similarly, the efficacy of the inverse agonist SB 207266 was not dependent on receptor density but was dependent on receptor structure; 3) when the receptor concentration increased, the EC50 values of the full agonist 5-HT were not modified and the increase in basal constitutive activity, as well as its stimulation by 5-HT, followed a parallel evolution; and 4) the stimulation of basal constitutive activity by 5-HT was not modified by the overexpression of Gas. All these results indicate that in COS-7 cells, the coupling of the 5-HT4 receptor to adenylyl cyclase was linear with no indication of spare receptors even at high receptor density (8 pmol/mg). These results are also in accordance with a precoupling between the activated receptor (f(R*)) and adenylyl cyclase. Such observations allowed us to use the two-state model to calculate the constant J, i.e., the equilibrium allosteric constant denoting the ratio of the receptor in the inactive versus active state (J = [R]/[R*]). We found that J was a receptor structural characteristic, independent of receptor density.
引用
收藏
页码:136 / 144
页数:9
相关论文
共 37 条
  • [1] [H-3]5-Hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT4 receptor
    Adham, N
    Gerald, C
    Schechter, L
    Vaysse, P
    Weinshank, R
    Branchek, T
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 304 (1-3) : 231 - 235
  • [2] Ambrosio C, 2000, MOL PHARMACOL, V57, P198
  • [3] [Anonymous], 5 HT4 RECEPTORS BRAI, DOI DOI 10.1038/nrgastro.2012.32
  • [4] Pharmacological comparison between [H-3]GR 113808 binding sites and functional 5-HT4 receptors in neurons
    Ansanay, H
    Sebben, M
    Bockaert, J
    Dumuis, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 298 (02) : 165 - 174
  • [5] DARK-ADAPTATION - A NEW HYPOTHESIS
    BARLOW, HB
    [J]. VISION RESEARCH, 1964, 4 (1-2) : 47 - 58
  • [6] The 5-HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5-HT4(c) receptor
    Blondel, O
    Gastineau, M
    Langlois, M
    Fischmeister, R
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (04) : 595 - 597
  • [7] 5-HT4 RECEPTORS - POTENTIAL THERAPEUTIC IMPLICATIONS IN NEUROLOGY AND PSYCHIATRY
    BOCKAERT, J
    ANSANAY, H
    WAEBER, C
    SEBBEN, N
    FAGNI, L
    DUMUIS, A
    [J]. CNS DRUGS, 1994, 1 (01) : 6 - 15
  • [8] BOCKAERT J, 1997, HDB EXPT PHARM SEROT, P439
  • [9] PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR
    BOND, RA
    LEFF, P
    JOHNSON, TD
    MILANO, CA
    ROCKMAN, HA
    MCMINN, TR
    APPARSUNDARAM, S
    HYEK, MF
    KENAKIN, TP
    ALLEN, LF
    LEFKOWITZ, RJ
    [J]. NATURE, 1995, 374 (6519) : 272 - 276
  • [10] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3